The Block • October 5th 2026, 8:42 AM
Injective CEO Eric Chen expects US INJ ETFs to launch sooner than 2027
Key Summary
Injective CEO Eric Chen has revised expectations for the launch of US Injective Network (INJ) exchange-traded funds (ETFs), now anticipating they will be launched sooner than initially predicted in 2027. Two ETF applications are currently pending, including the 21Shares Injective ETF and the Canary Staked INJ ETF, with no official timeline provided for their launch.
Please see our real time news feed on our Home Page
There are currently two ETF applications tied to INJ — the 21Shares Injective ETF and the Canary Staked INJ ETF.